TUESDAY, May 26, 2020 (HealthDay News) — Air pollution might increase the risk for multiple sclerosis (MS), Italian researchers report. They found that in places with low levels of tiny particles of air pollution called particulate matter, the risk for MS was lower than in areas where those levels wereContinue Reading
THURSDAY, May 21, 2020 (HealthDay News) — A new blood test might help doctors predict whether someone’s multiple sclerosis may soon get worse. The test looks for a substance called neurofilament light chain. It’s a nerve protein that can be detected when nerve cells die. People with higher levels ofContinue Reading
WEDNESDAY, March 18, 2020 (HealthDay News) — Brain inflammation may be more of a factor in dementia than previously believed, a new British study suggests. “We predicted the link between inflammation in the brain and the buildup of damaging proteins, but even we were surprised by how tightly these twoContinue Reading
WEDNESDAY, Feb. 5, 2020 (HealthDay News) — A new discovery could lead to better treatments for multiple sclerosis (MS) and other autoimmune diseases, such as psoriasis and rheumatoid arthritis, researchers report. MS occurs when immune cells get into the central nervous system (the brain and spinal cord), causing nerve damageContinue Reading
WEDNESDAY, June 12, 2019 (HealthDay News) — Obesity can worsen multiple sclerosis symptoms, researchers say. Their study involved 140 patients with the relapsing-remitting form of MS, which means patients have periods of attacks (relapses), followed by periods of remission with no or few symptoms. The researchers found that obesity atContinue Reading
THURSDAY, April 11, 2019 (HealthDay News) — Almost one in five multiple sclerosis patients may be misdiagnosed with the autoimmune disease, according to a new study. Of 241 previously diagnosed multiple sclerosis (MS) patients referred to two major Los Angeles medical centers for treatment, nearly 18% did not actually haveContinue Reading
THURSDAY, March 28, 2019 (HealthDay News) — An older but still common multiple sclerosis (MS) treatment has an unexpected perk: It not only quells symptoms, but patients may also live longer. New research revealed that patients taking a beta interferon drug for more than three years were likely to liveContinue Reading
FRIDAY, March 22, 2019 (HealthDay News) — Proper treatment can help people with multiple sclerosis (MS) contend with their disease, an expert says. “Patients get a predisposed feeling that their life is doomed. That it’s going to be a complicated life, which isn’t necessarily so,” said Dr. Cary Twyman, aContinue Reading
TUESDAY, March 5, 2019 (HealthDay News) — Fatigue can plague many people with multiple sclerosis (MS). But a small new study suggests a soothing cup of hot cocoa may bring some relief. Like dark chocolate, cocoa is rich in flavonoids, which are abundant in fruit and vegetables and have beenContinue Reading
(HealthDay News) — Fatigue occurs in more than 80 percent of people with MS, the National Multiple Sclerosis Society says. The society suggests including these approaches to managing fatigue: Regulate your sleep, which might involve treating other MS symptoms that interfere with sleep (ie., spasticity, urinary problems). Psychological interventions, suchContinue Reading
WEDNESDAY, Dec. 19, 2018 (HealthDay News) — Researchers say they’ve identified a potential link between food allergies and flare-ups of multiple sclerosis. “Our findings suggest that MS patients with allergies have more active disease than those without, and that this effect is driven by food allergies,” said study author Dr.Continue Reading
FRIDAY, Sept. 28, 2018 (HealthDay News) — Living with a potentially disabling condition like multiple sclerosis (MS) can be difficult, but new research suggests patients get better at dealing with it over time. “There’s an aging paradox in healthy adults. We expect people who are older to be more depressedContinue Reading
THURSDAY, Aug. 23, 2018 (HealthDay News) — A new subtype of multiple sclerosis (MS) has been identified by researchers, and the discovery changes understanding of the disease. MS has long been considered a disease of the brain’s white matter, where immune cells destroy the fatty protective covering (myelin) on nerveContinue Reading
These regimens raised the risk for disease relapse, study foundContinue Reading